$AKUS Akouos, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Akouos, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Akouos, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Akouos, Inc. for free.

CIK Number: 0001722271
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AKUS
Company Address: 645 SUMMER STREET, SUITE 200 BOSTON 02210
Phone number: 857-245-5715

Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA.

Akouos, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 25 2021AKUSAkouos, Inc.SATO VICKI LDirectorOption ExerciseA13.3916,000214,24016,000
Feb 17 2021AKUSAkouos, Inc.Minegishi SachiyoChief Financial Off ...Option ExerciseA17.9715,000269,55015,000
Feb 17 2021AKUSAkouos, Inc.McKenna Michael JohnChief Medical Offic ...Option ExerciseA17.9770,0001,257,90070,000
Feb 17 2021AKUSAkouos, Inc.Wellman Jennifer AnneChief Operating Off ...Option ExerciseA17.97100,0001,797,000100,000
Feb 17 2021AKUSAkouos, Inc.Robinson Gregory ScottChief Scientific Of ...Option ExerciseA17.9760,0001,078,20060,000
Feb 17 2021AKUSAkouos, Inc.Simons EmmanuelChief Executive Off ...Option ExerciseA17.97250,0004,492,500250,000
Dec 31 2020AKUSAkouos, Inc.PARMAR KUSHDirectorSellS18.00111,6482,009,664982,4531.1 M to 982.5 K (-10.20 %)
Dec 31 2020AKUSAkouos, Inc.PARMAR KUSHDirectorSellS18.00111,6482,009,664982,4531.1 M to 982.5 K (-10.20 %)
Dec 31 2020AKUSAkouos, Inc.PARMAR KUSHDirectorSellS18.00358,3526,450,3363,153,3313.5 M to 3.2 M (-10.20 %)
Dec 31 2020AKUSAkouos, Inc.PARMAR KUSHDirectorSellS18.00358,3526,450,3363,153,3313.5 M to 3.2 M (-10.20 %)
Dec 31 2020AKUSAkouos, Inc.5AM Ventures V, L.P.10% OwnerSellS18.00111,6482,009,664982,4531.1 M to 982.5 K (-10.20 %)
Dec 31 2020AKUSAkouos, Inc.5AM Ventures V, L.P.10% OwnerSellS18.00111,6482,009,664982,4531.1 M to 982.5 K (-10.20 %)
Dec 31 2020AKUSAkouos, Inc.5AM Ventures V, L.P.10% OwnerSellS18.00358,3526,450,3363,153,3313.5 M to 3.2 M (-10.20 %)
Dec 31 2020AKUSAkouos, Inc.5AM Ventures V, L.P.10% OwnerSellS18.00358,3526,450,3363,153,3313.5 M to 3.2 M (-10.20 %)
Oct 15 2020AKUSAkouos, Inc.Minegishi SachiyoCHIEF FINANCIAL OFF ...Option ExerciseA22.45257,7805,787,161257,780

View all Akouos, Inc. insider transactions.